GGrantIndex
← Leaderboards

Kathleen R. Cho

University Of Michigan At Ann Arbor

$7,394,597
Attributed
$7,394,597
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $576.9K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,394,597 · 7

By mechanism

R01$7,054,878 · 4
P30$236,011 · 1
U19$103,708 · 1
P50$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Carcinoma

Research focus

CarcinomaGene MutationMutationCellsMalignant NeoplasmsPathway InteractionsResponsePathogenesisWomanGene ExpressionMalignant Neoplasm Of OvarySerousSurfaceMouse ModelTumorOvarianBaseEpitheliumGene TargetingGenesMolecularLesionSomatic MutationGenetic

Grant awards (29)

Cancer Genetics (CG)$80,150
P30 · FY2025 · CA · contact PI
Cancer Genetics (CG)$77,090
P30 · FY2024 · CA · contact PI
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice$498,165
R01 · FY2023 · CA · contact PI
Cancer Genetics (CG)$78,771
P30 · FY2023 · CA · contact PI
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice$498,165
R01 · FY2022 · CA · contact PI
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice$508,332
R01 · FY2021 · CA · contact PI
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice$533,016
R01 · FY2020 · CA · contact PI
Modeling Factors Associated with Risk of High-Grade Serous Carcinoma in Mice$533,016
R01 · FY2019 · CA · contact PI
Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm$489,122
R01 · FY2018 · CA · contact PI
Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm$489,123
R01 · FY2017 · CA · contact PI
Credentialing Ovarian Cancer Models in the Context of the Dualistic Pathway Paradigm$471,755
R01 · FY2016 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas$253,343
R01 · FY2011 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas$261,178
R01 · FY2010 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas$261,178
R01 · FY2009 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas$261,178
R01 · FY2008 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas$261,178
R01 · FY2007 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$262,464
R01 · FY2006 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$54,167
R01 · FY2006 · CA · contact PI
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$268,780
R01 · FY2005 · CA
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$53,804
R01 · FY2005 · CA
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$268,780
R01 · FY2004 · CA
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$50,487
R01 · FY2004 · CA
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$268,780
R01 · FY2003 · CA
MOLECULAR MARKERS FOR CERVICAL CANCER PROGRESSION$0
P50 · FY2003 · CA
Molecular Pathogenesis of Ovarian Endometrioid Adenocarc$268,780
R01 · FY2002 · CA
OVARIAN TUMOR PROJECT$0
U19 · FY2002 · CA
OVARIAN TUMOR PROJECT$0
U19 · FY2001 · CA
FHIT GENE ALTERATIONS IN CERVICAL CANCER PATHOGENESIS$240,087
R01 · FY2000 · CA
OVARIAN TUMOR PROJECT$103,708
U19 · FY2000 · CA